Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;16(1):43-50.
doi: 10.2174/1570159X15666170504122410.

Substance P Regulation in Epilepsy

Guangfan Chi  1 , Zhehao Huang  2 , Xianglan Li  2 , Kun Zhang  3 , Guangquan Li  3
Affiliations
Review

Substance P Regulation in Epilepsy

Guangfan Chi et al. Curr Neuropharmacol. 2018.

Abstract

Background: Epilepsy is a common neurological disease characterized by abnormal temporary discharge of neurons in the central nervous system. In recent years, studies have revealed the localization and changes in the density of neuropeptides, such as substance P (SP) in the pathogenesis of epilepsy. This review is a concise overview of SP and their physiologic and pathologic functions on regulating epilepsy, and the underline mechanisms.

Methods: We research and collect relative online content for reviewing the effects of SP in Epilepsy.

Results: The SP/NK-1 receptor system may induce seizures and play an important role in status epilepticus and in experimental animal models of epilepsy. Newest studies show that several mechanisms may explain the excitatory effects of the SP/NK-1 receptor signaling pathway in epilepsy. By binding to the NK-1 receptor, NK-1 receptor antagonists may block the pathophysiological effects of SP, and further studies are needed to confirm the possible anti-epileptic activity of NK-1 receptor antagonists.

Conclusion: SP plays crucial roles on through binding with NK-1 receptor during epilepsy pathologic processing, and the NK-1 receptor is receiving a great attention as a therapeutic target for treating epilepsy. Thus, the use of NK-1 receptor antagonists for the treatment of epilepsy should be investigated in further studies.

Keywords: Animal; GABA; NK-1; Neuron; epilepsy; substance P.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Manjarrez-Marmolejo J., Franco-Pérez J. Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models. Curr. Neuropharmacol. 2016;14(7):759–771. doi: 10.2174/1570159X14666160603115942. - DOI - PMC - PubMed
    1. Liu W., Ge T., Pan Z., Leng Y., Lv J., Li B. The effects of herbal medicine on epilepsy. Oncotarget. 2017;8:48385–48397. - PMC - PubMed
    1. Kim J.H. Pathology of seizure disorders. Neuroimaging Clin. N. Am. 1995;5(4):527–545. [PMID: 8564282]. - PubMed
    1. Brooks-Kayal A.R., Shumate M.D., Jin H., Rikhter T.Y., Coulter D.A. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 1998;4(10):1166–1172. [http://dx.doi.org/10.1038/2661]. [PMID: 9771750]. - PubMed
    1. Naylor D.E., Liu H., Wasterlain C.G. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J. Neurosci. 2005;25(34):7724–7733. [http://dx.doi.org/10.1523/JNEUROSCI.4944-04.2005]. [PMID: 16120773]. - PMC - PubMed